ACLS vs AEHR Stock Comparison

ACLS currently leads AEHR in this stock comparison, with AIQ scores of 48 vs 31. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 17 points
ACLS
Technology
vs
AEHR
Technology
ACLS
Axcelis Technologies, Inc.
Leads
Price
$104
Day move
-3.37%
AIQ Score
48/100
Best edge
Value
Sector
Technology
AEHR
Aehr Test Systems
Price
$56.98
Day move
-6.65%
AIQ Score
31/100
Best edge
Balanced
Sector
Technology

What is the main difference between ACLS and AEHR?

ACLS leads the current stock comparison as Axcelis Technologies, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Axcelis Technologies, Inc. vs Aehr Test Systems

Data as of Nov 15, 2026· market close· Technology· Coverage 66/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

ACLS leads

ACLS leads by 17 AIQ points, primarily on Value and Quality, and the lead has widened from 12 points over 30 sessions. Wall Street currently favors AEHR on target upside.

Stable: 5 of 6 evidence groups support ACLS, and its lead is widening.

Evidence agreement: 5 of 6Comparison trend: Strengthening
ACLS

Axcelis Technologies, Inc.

Leads
AIQ Score
48/100
AIQ Edge Score
5/10
AEHR

Aehr Test Systems

AIQ Score
31/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors ACLS over AEHR, 48 versus 31 as of Nov 15, 2026. ACLS's advantage is driven primarily by stronger value and quality. ACLS also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AEHR. 5 of 6 covered evidence groups favor ACLS today, and the comparison is rated Stable on stability. ACLS lead: Strengthening — the AIQ differential moved from 12 to 17 points over 30 sessions. ACLS leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Axcelis Technologies, Inc. and Aehr Test Systems across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ACLS
+65.7%
AEHR
+145.1%

Price return comparison

Growth of $10,000, price only

ACLS $16,569 · AEHR $24,508

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ACLS and AEHR against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ACLS advantage
0
AEHR advantage
  • Value68 vs 24
    ACLS +44
  • Quality51 vs 40
    ACLS +11
  • Risk Resilience35 vs 24
    ACLS +11
  • Momentum38 vs 30
    ACLS +8

5 of 6 evidence groups favor ACLS. ACLS’s edge is concentrated in value and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ACLS+1 AIQ

Largest factor move: Quality -1

No signal started or stopped since the prior session; its 5 active signals are unchanged.

AEHR0 AIQ

No factor moved materially.

No signal started or stopped since the prior session; its 3 active signals are unchanged.

ACLS's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ACLS and AEHR both carry a full feed there.

The central trade-off

ACLS (Axcelis Technologies, Inc.): the stronger current systematic profile, led by value and quality.

AEHR (Aehr Test Systems): the counter-case, on analyst expectations — but at materially higher volatility, 166.2% against 84.8%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ACLS

ACLS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

ACLS

ACLS on the peer-relative Value factor, by 44 points.

Momentum

ACLS

ACLS on the Momentum factor, by 8 points.

Lower downside

ACLS

ACLS on Risk Resilience, by 11 points.

Analyst upside

AEHR

AEHR on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ACLS, analyst targets favor AEHR. That disagreement is the most useful thing on this page.

MeasureACLSAEHRNote
Implied upside to target+58%+110.6%AEHR has more room
Target dispersion0%0%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering66Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 6 covered evidence groups favor ACLS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreACLS48 vs 31
FundamentalsACLSon balancerevenue growth 10.5% vs 67.1%; EPS growth 60.5% vs 3.4%; TTM ROE 3.4% vs 3.2%; gross margin 42.8% vs 40.6%; operating margin 10.3% vs -5.5% — ACLS takes 3 of 4 decided legs, not all of them
ValuationACLSValue 68 vs 24
TechnicalsACLSPrice vs 50-day -9.3% vs -26.9%; vs 200-day -15.5% vs -24.9%
Risk ResilienceACLSRisk Resilience 35 vs 24
Analyst expectationsAEHRTarget upside 58% vs 110.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ACLS and AEHR and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 17 points. (supports the conclusion holding)
  • 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ACLS.

How the comparison changed

79 daily snapshots · Jul 27 – Nov 13

ACLS lead: Strengthening — the AIQ differential moved from 12 to 17 points over 30 sessions.

Jul 27ACLS leads above the line · AEHR leads belowNov 13
Today
ACLS +17
48 vs 31
7 sessions ago
ACLS +15
45 vs 30
30 sessions ago
ACLS +12
54 vs 42
90 sessions ago
ACLS +7
56 vs 49

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ACLS

0 bullish / 3 bearish / 2 neutral

Only ACLS

  • Death Cross Active — bearish, trend, long horizon (7.34%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
AEHRConflicted

1 bullish / 1 bearish / 1 neutral, conflicted

Only AEHR

  • Golden Cross Active — bullish, trend, long horizon (2.70%)

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning.

AEHR is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ACLSDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -3.37%, AIQ +1 points).

AEHRNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -6.65%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AEHR closes the Value gap — currently 44 points behind, the largest single contributor to ACLS's edge.
  2. 2AEHR's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3ACLS starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ACLS leads on balance
MetricACLSAEHR
Revenue growth (YoY)10.5%67.1%
EPS growth (YoY)60.5%3.4%
Gross margin42.8%40.6%
Operating margin10.3%-5.5%
Return on equity (TTM)3.4%3.2%
Debt to equity0.040.04

Performance

Split across windows
MetricACLSAEHR
1 week (5 sessions)5.2%6.4%
1 month (20 sessions)-3.6%-6%
3 months (63 sessions)-27.5%-60.9%
6 months (126 sessions)-32.7%-42.7%
Year to date30%182.2%
1 year (252 sessions)22.2%145.4%

Technicals

ACLS has the stronger structure
MetricACLSAEHR
RSI (14)45.743.2
ADX (14)24.126.8
Price vs 50-day-9.3%-26.9%
Price vs 200-day-15.5%-24.9%
Volatility (1M, annualized)84.8%166.2%

Risk

ACLS is the more resilient
MetricACLSAEHR
Beta2.645.43
Sharpe ratio0.631.38
Sortino ratio0.922.29
Max drawdown-53%-66.2%
Current drawdown-45.5%-60.9%
Annualized volatility71.4%129.5%
Value at risk (95%)-6.2%-12%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ACLS or AEHR?

On the Algovestiq AIQ Score, ACLS is the stronger of the two as of Nov 15, 2026, scoring 48 against AEHR's 31. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ACLS or AEHR the better buy right now?

ACLS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ACLS over AEHR?

The composite weights Quality, Value, Momentum and Risk Resilience. ACLS leads Value by 44 points; ACLS leads Quality by 11 points; ACLS leads Risk Resilience by 11 points. ACLS leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by AEHR simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, ACLS or AEHR?

Analyst price targets imply +58% upside for ACLS and +110.6% for AEHR, so the Street currently favors AEHR. That points the opposite way to the AIQ Score, which favors ACLS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ACLS or AEHR?

ACLS is the better-valued of the two on the peer-relative Value factor. ACLS on the peer-relative Value factor, by 44 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ACLS or AEHR?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ACLS or AEHR?

ACLS on the Momentum factor, by 8 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ACLS or AEHR?

ACLS is the more resilient of the two, so the other name carries the higher downside risk. ACLS on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ACLS more profitable than AEHR?

ACLS leads on the comparable margin measures — gross margin 42.8% vs 40.6%; operating margin 10.3% vs -5.5%; ttm roe 3.4% vs 3.2%.

Is ACLS's lead over AEHR getting stronger or weaker?

ACLS lead: Strengthening — the AIQ differential moved from 12 to 17 points over 30 sessions. This is measured from 79 daily comparison snapshots between 2026-07-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ACLS vs AEHR verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AEHR closes the Value gap — currently 44 points behind, the largest single contributor to ACLS's edge; AEHR's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; ACLS starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ACLS and AEHR?

ACLS: 0 bullish / 3 bearish / 2 neutral. AEHR: 1 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ACLS is Death Cross Active (bearish, long horizon). On AEHR it is Golden Cross Active (bullish, long horizon).

Compare ACLS and AEHR with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.